![](/img/cover-not-exists.png)
CO26. Results of a phase 1/2 study for KW-0761, a monoclonal antibody directed against CC chemokine receptor type 4 (CCR4), in CTCL patients
Kim, Y.H., Pinter-Brown, L., Foss, F., Sokol, L., Jorgensen, J.L., Spitalny, G.L., Duvic, M.Volume:
21
Language:
english
Journal:
Melanoma Research
DOI:
10.1097/01.cmr.0000399460.48119.fe
Date:
June, 2011
File:
PDF, 58 KB
english, 2011